Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
KRONOS: PT010 vs Dual Therapies and Symbicort in COPD
NCT02497001Phase 3Completed
- Sponsor
- Pearl Therapeutics
- Start
- Aug 2015
- Primary completion
- Jan 2018
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 3 trial of budesonide, glycopyrrolate metered dose inhaler, formoterol fumarate in chronic obstructive pulmonary disease (COPD), sponsored by Pearl Therapeutics. Started Aug 2015; status: completed.
02
Drugs
budesonideglycopyrrolate metered dose inhalerformoterol fumarate
03
Conditions
chronic obstructive pulmonary disease (COPD)
Beyond the preview
Go deeper on NCT02497001.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02497001.